Search Results - "Estival, A."

SEOM clinical guideline on unknown primary cancer (2017) by Losa, F., Soler, G., Casado, A., Estival, A., Fernández, I., Giménez, S., Longo, F., Pazo-Cid, R., Salgado, J., Seguí, M. Á.

“…Cancer of unknown primary site is a histologically confirmed cancer that manifests in advanced stage, with no identifiable primary site following standard…”
Get full text

Occult triple negative male breast cancer. The usefulness of molecular platforms. A case report by L, Angelats, A, Estival, A, Martinez-Cardús, E, Musulen, M, Margelí

“…We report a case of a 68-year-old man who developed an advanced Triple-Negative Breast Cancer (TNBC) presented as a Carcinoma of Unknown Primary (CUP) at…”
Get full text

SEOM Clinical Guideline of management of soft-tissue sarcoma (2020) by de Juan Ferré, A., Álvarez Álvarez, R., Casado Herráez, A., Cruz Jurado, J., Estival González, A., Martín-Broto, J., Martínez Marín, V., Moreno Vega, A., Sebio García, A., Valverde Morales, C.

“…Soft-tissue sarcomas constitute an uncommon and heterogeneous group of tumors of mesenchymal origin. Diagnosis, treatment, and management should be performed…”
Get full text

Influence of glioblastoma contact with the subventricular zone on survival and recurrence patterns by Comas, S., Luguera, E., Molero, J., Balaña, C., Estival, A., Castañer, S., Carrato, C., Hostalot, C., Teixidor, P., Villà, S.

“…Background There is growing evidence that the subventricular zone (SVZ) may be involved in both the initiation and progression of glioblastoma (GB). We aimed…”
Get full text

SEOM Clinical Guideline for gastrointestinal sarcomas (GIST) (2016) by Poveda, A., Martinez, V., Serrano, C., Sevilla, I., Lecumberri, M. J., de Beveridge, R. D., Estival, A., Vicente, D., Rubió, J., Martin-Broto, J.

“…Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal neoplasms of the digestive tract, and this disease has served as a paradigmatic model…”
Get full text

Lack of Evidence That High Dose of Radiation in Subventricle Zone (SVZ) Can Improve the Outcome in Glioblastoma (GB): Report on a Cohort of Patients by Comas, S, Villa, S, Velarde, J.M, Molero, J, Estival, A, Teixidor, P, Guitierrez, B, Luis, Y, Perez, G, Panciroli, C, Balana, C

Get full text

Assessment of neurocognitive decline in cancer patients, except brain cancer, under long-term treatment with bevacizumab by Panciroli, C., Lucente, G., Vidal, L., Carcereny, E., Quiroga, V., Pardo, J. C., Romeo, M., Estival, A., Manzano, J. L., Pardo, B., Velarde, J. M., Esteve, A. M., Lopez, D., Mañes, A., Tuset, V., Villà, S., Quintero, C. B.

“…Purpose We performed a cross-sectional study of neurocognitive function in non-brain cancer patients treated with long-term bevacizumab. Methods/patients From…”
Get full text

HTA202 Learnings From First TC Opinions of Drugs Evaluated for EAP Under New Process by Estival, A

Get full text

3103 Impact of three and further treatment lines in advanced Non-Small Cell Lung Cancer patients according to molecular profile: A retrospective analysis by Werbin, M. Hardy, Moran, T, Teruel, I, Vila, L, Moreno, M. Gil, Perez, G, Centeno, C, Tudela, C, Raya, P, Andreo, F, Mate, J.L, Margeli, V, Estival, A, Carcereny, E

Get full text

SEOM clinical guideline on unknown primary cancer (2017) by Losa, F., Soler, G., Casado, A., Estival, A., Fernández, I., Giménez, S., Longo, F., Pazo-Cid, R., Salgado, J., Seguí, M. Á.

Get full text

Results of a multicenter survey showing interindividual variability among neurosurgeons when deciding on the radicality of surgical resection in glioblastoma highlight the need for more objective guidelines by Capellades, J., Teixidor, P., Villalba, G., Hostalot, C., Plans, G., Armengol, R., Medrano, S., Estival, A., Luque, R., Gonzalez, S., Gil-Gil, M., Villa, S., Sepulveda, J., García-Mosquera, J. J., Balana, C.

“…Purpose We assessed agreement among neurosurgeons on surgical approaches to individual glioblastoma patients and between their approach and those recommended…”
Get full text

Delay in starting radiotherapy due to neoadjuvant therapy does not worsen survival in unresected glioblastoma patients by Balaña, C., Estival, A., Teruel, I., Hardy-Werbin, M., Sepulveda, J., Pineda, E., Martinez-García, M., Gallego, O., Luque, R., Gil-Gil, M., Mesia, C., Del Barco, S., Herrero, A., Berrocal, A., Perez-Segura, P., De las Penas, R., Marruecos, J., Fuentes, R., Reynes, G., Velarde, J. M., Cardona, A., Verger, E., Panciroli, C., Villà, S.

“…Purpose We retrospectively examined the potential effect on overall survival (OS) of delaying radiotherapy to administer neoadjuvant therapy in unresected…”
Get full text

HTA129 Learnings from TC Opinions of Drugs Evaluated for EAP Under New Process by Estival, A., Caron, A.

Get full text

Comparison of two types of inocula during acclimation and stable operation for nitrophenol biodegradation in an anaerobic-aerobic SBR by Vargas, A, González, D, Estival, A, Buitrón, G

“…This work presents a comparison of two inocula used for the acclimation of two anaerobic-aerobic sequencing batch bioreactors used for toxic wastewater…”
Get full text

Sub-Ventricular Zone Contact Influences Survival and Relapse Pattern in Glioblastoma by Anton, S. Comas, Molero, J., Luguera, E., Balaña, C., Estival, A., Carrato, C., Castañer, S., Baena, E., Villa, S.

Get full text

1309P A multicenter phase I study of radium-223 (Ra-223) plus pembrolizumab in patients with stage IV non-small cell lung cancer (NSCLC) by Reck, M., Mileham, K., Paz-Ares, L., Surmont, V., Felip, E., Viñolas, N., Bessudo, A., Clump, D., Decoster, L., Estival, A., Sebastian, M., Chen, H., Chisamore, M., Wagner, V.J., Wagner, A., Smit, E.F.F.

Get full text

1420TiP A phase I/II trial of radium-223 (Ra-223) in combination with pembrolizumab in patients (pts) with stage IV non-small cell lung cancer (NSCLC) by Reck, M., Mileham, K.F., Clump, D.A., Decoster, L., Estival, A., Felip, E., Fried, P., Paz-Ares, L., Sebastian, M., Segarra, N. Vinolas, Surmont, V., Wagner, A., Galdy, S.M., Smit, E.F.

Get full text

1168P Clinical characteristics and survival in stage I-IIIA lung cancer resected patients in Spain, analyzed in the Thoracic Tumors Registry (TTR) by Franco, F.F., Carcereny, E., Castro, R. Lopez, Rodriguez, D., Dols, M.A. Cobo, Caro, R. Bernabe, Cordellat, A. Blasco, Sureda, B. Massuti, Granados, A.L. Ortega, Barco, E. del, Bosch-Barrera, J., Guirado, M., Gonzalez-Larriba, J.L., Vidal, O. Juan, Martinez, J. Mosquera, Rodriguez, J.M. Oramas, Gonzalez, M.A. Sala, Calvo, V., Gonzalez, A. Estival, Provencio, M.

Get full text

1591P Immune response after vaccination against SARS-COV-2 in lung cancer (LC) patients (p). Prospective study in the Medical Oncology Department at the Catalan Institute of Oncology-Badalona, Spain: COVID-lung vaccine by Felip, E., Hernandez, A., Notario, L., Cucurull, M., Quirant, B., Saigí, M., Gómez-Castellà, R., Estevez-Macas, E., Fonollosa, S. Coll, Bertral, P. Torres, Costa, E. Carcereny, Domenech, M., Estival, A., Paradís, A. López, Badía, A. Pous, Marín, M. Romeo, Bueno, M.T. Moran

Get full text

1380P Description of the clinical characteristics and survival in patients with metastatic NSCLC in the Spanish population: An analysis of the thoracic tumours registry (RTT study) by Franco, F., Costa, E. Carcereny, Rodriguez-Abreu, D., Castro, R. Lopez, Dols, M. Cobo, Guirado, M., Sureda, B. Massuti, Granados, A.L. Ortega, Campelo, R. Garcia, Juan-Vidal, O., Cordellat, A. Blasco, Morillo, E. del Barco, Caro, R. Bernabe, Bosch-Barrera, J., Gonzalez-Larriba, J.L., Gonzalez, M.A. Sala, Perez, J.M. Trigo, Rodriguez, J.M. Oramas, Estival, A., Pulla, M. Provencio

Get full text